Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001047469-01-000600
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 0001.txt SC 13G 14474
2 RELEVANT SUBSIDIARIES OF PARENT HOLDING COMPANY 0002.txt EX-99.A 1660
3 JOINT FILING AGREEMENT 0003.txt EX-99.B 1761
  Complete submission text file 0001047469-01-000600.txt   20066
Mailing Address 865 SOUTH FIGUEROA STREET LOS ANGELES CA 90017
Business Address 865 SOUTH FIGUEROA ST LOS ANGELES CA 90017
TCW GROUP INC (Filed by) CIK: 0000850401 (see all company filings)

SIC: 6798 Real Estate Investment Trusts

Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46083 | Film No.: 1543987
SIC: 2836 Biological Products, (No Diagnostic Substances)